Featured
Regulatory Approval Fuels Uptrend In Vivos Therapeutics (VVOS) Stock
Following a significant regulatory development, shares of Vivos Therapeutics, Inc. (NASDAQ: VVOS) increased significantly on Tuesday. VVOS stock was up 22.15% to $3.86 as of